DBV Technologies S.A. (EPA:DBV)
3.390
+0.010 (0.30%)
May 14, 2026, 5:37 PM CET
DBV Technologies Employees
DBV Technologies had 161 employees as of March 31, 2026. The number of employees increased by 55 or 51.89% compared to the same quarter last year.
Employees
161
Change
55
Growth
51.89%
Revenue / Employee
€30,900
Profits / Employee
€902,030
Market Cap
1.00B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 161 | 55 | 51.89% | 161 | 0 |
| Dec 31, 2025 | 126 | 16 | 14.55% | 125 | 1 |
| Sep 30, 2025 | 117 | 9 | 8.33% | 117 | 0 |
| Jun 30, 2025 | 109 | 3 | 2.83% | 109 | 0 |
| Mar 31, 2025 | 106 | 1 | 0.95% | 106 | 0 |
| Dec 31, 2024 | 110 | 5 | 4.76% | 109 | 1 |
| Sep 30, 2024 | 108 | 11 | 11.34% | 108 | 0 |
| Jun 30, 2024 | 106 | 18 | 20.45% | 106 | 0 |
| Mar 31, 2024 | 105 | 17 | 19.32% | 105 | 0 |
| Dec 31, 2023 | 105 | 19 | 22.09% | 104 | 1 |
| Sep 30, 2023 | 97 | 12 | 14.12% | 97 | 0 |
| Jun 30, 2023 | 88 | 1 | 1.15% | 88 | 0 |
| Mar 31, 2023 | 88 | 0 | - | 88 | 0 |
| Dec 31, 2022 | 86 | -6 | -6.52% | 85 | 1 |
| Sep 30, 2022 | 85 | -7 | -7.61% | 85 | 0 |
| Jun 30, 2022 | 87 | -10 | -10.31% | 87 | 0 |
| Mar 31, 2022 | 88 | -16 | -15.38% | 88 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| MedinCell | 145 |
| Transgene | 145 |
| Nanobiotix | 100 |
| Inventiva | 77 |
| ABIVAX Société Anonyme | 69 |
DBV Technologies News
- 21 hours ago - Combined General Meeting of June 3, 2026 - GlobeNewsWire
- 1 day ago - DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq - GlobeNewsWire
- 10 days ago - DBVT Reiterated by Guggenheim -- Price Target Maintained at $51.00 - GuruFocus
- 12 days ago - DBVT Maintained by Citizens -- Price Target Raised to $55.00 - GuruFocus
- 13 days ago - DBV Technologies price target raised to $55 from $47 at Citizens - TheFly
- 13 days ago - DBVT SWOT Analysis: Financial Challenges and Growth Potential Revealed in 10-Q Filing - GuruFocus
- 13 days ago - Is DBV Technologies (DBVT) Fairly Valued After Q1 2026 Results? EPS $(0. ... - GuruFocus
- 13 days ago - DBVT Advances Peanut Allergy Treatments with Upcoming Clinical Studies - GuruFocus